OM DENNE EPISODE
Friday, October 2, 2026 — Week 40
CENSUS — 1,871 AND GROWING
- Q3 census: 1,871 known patients, +65 this quarter.
- First patient in Rwanda. USA +11, China +16, Brazil +6, France +4.
- Finding patients matters more than ever as trials approach. https://cureSYNGAP1.org/Census
COMBINEDBRAIN — RARE RESEARCH ROUNDTABLE
- Wonderful Rare Research Roundtable on Genetic Neurodevelopmental Disorders. COMBINEDBrain is a gift to the rare neuro community — hug them when you see them. https://combinedbrain.org/RR-RGND
- Dr. Emma James of Encoded, chair of our IAB, posted about the meeting. https://www.linkedin.com/posts/emma-james-71759a1a_the-combinedbrain-research-roundtable-on-ugcPost-7511223599165472768-jDkI
CURE SYNGAP1 CONFERENCE — DENVER
- 9 Family Legacy Sponsors, up from 8 in 2025.
- Thursday Rare Reception — free, register: https://cureSYNGAP1.org/RR26
- Friday Family Dinner at Henry’s: https://cureSYNGAP1.org/Henrys
- Conference registration ends OCT. 31. https://cureSYNGAP1.org/Reg26
UNLOCK THEIR TOMORROW
- Q4 goal: $500,000 by Dec. 31, including a $200,000 match.
- Families can start their own fundraiser; anyone can donate. https://cureSYNGAP1.org/Unlock
- Your Idea. Your Fundraiser. Your SYNGAP1 Impact. https://curesyngap1.org/blog/your-idea-your-fundraiser-your-syngap1-impact
COMMUNITY ACTION
- RARE Disease Week 2027, March 2-4, in DC. Travel reimbursement applications are open; deadline Nov. 6. https://bit.ly/4jo7fku
- RARE Foundation travel reimbursement post: https://www.facebook.com/share/p/1EeF8jTWFi
• Sign up for ARI: https://cureSYNGAP1.org/Ari
WARRIORS — JACK
- Jack is a 3-year-old from Berkeley who missed early milestones and was diagnosed with SYNGAP1 around age 3 after eyelid-fluttering episodes led to EEG, MRI and genetic testing. https://curesyngap1.org/syngap-warriors/jack-w
NEWSLETTER #52
- All the latest news and links in one place: https://cureSYNGAP1.org/NL52
- Subscribe: https://cureSYNGAP1.org/Newsletter
PUBMED + SCIENCE
- PubMed 2026: 54. +14 vs Week 40. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date
USA - Use your ICD-10: F78.A1
SOCIAL MATTERS
5,301 LinkedIn. https://www.linkedin.com/company/cureSYNGAP1
1.63k YouTube. https://www.youtube.com/@CureSYNGAP1
11.0k X. https://twitter.com/cureSYNGAP1
43.4k Instagram. https://www.instagram.com/cureSYNGAP1
Like + subscribe wherever you listen. https://cureSYNGAP1.org/podcasts/syngap10
Episode 222 of #Syngap10 #SYNGAP1 #CureSYNGAP1 #Podcast #PatientAdvocacy
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af CURE SYNGAP1 PODCAST aka SYNGAP10.
ANDRE EPISODE I DENNE PODCAST
#Future4Ford. 2Q26 #SYNGAP1Census = 1,806 Patients (+45) $CAMP #ValproateDemandBetter #S10e212
Saturday, July 4, 2026 - Week 27
#Future4Ford! Already at $3,500+! Share. Thank you to the Family.
This is the model for newly diagnosed, call us, set up a page, help us help your loved one. cureS…
Monday, August 10, 2026 - Week 33
Make sure to watch #S10e213 first! https://www.linkedin.com/posts/curesyngap1_camp4-trial-approved-in-australia-argentina-activity-7491598254027984896-wWTg
145 done! Out of 516 in US per last census: (https://www.linkedin.com/posts/curesyngap1_syngap1census-s…
Friday, August 7, 2026 - Week 32
CAMP4 - Gaining momentum
- Approval for trials in Australia & +$50M of cash from investors:https://investors.camp4tx.com/news-releases/news-release-details/camp4-therapeutics-secures-australian-regulatory-clearance
- Profile on CNBC Cures: https://www.cnbc…
Tony with us for a week after five months away…
Way less screen addicted
More independent
Chubby - Less exercise, worse food
Depressed
Adam’s Camp was great as usual
The support model was striking: the camper-to-therapist ratio was close to one-to-one, with skilled professionals in sp…
Sunday, August 30, 2026 — Week 36
TRIALS & DATA — CAMP4, RARE-X + ProMMiS
CAMP4 / CMP-002
Australia and Argentina cleared.
EU and UK filings underway.
First-in-human Phase 1/2 study still targeted for Q4 2026.
CMP-002 is designed to increase expression of the healthy SYNGAP1 copy.
CAMP4 …
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Syngap Research Fund, 501(c)(3), som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.